Free Trial

Lifecore Biomedical (LFCR) Institutional Ownership

Lifecore Biomedical logo
$4.56 +0.06 (+1.33%)
As of 11:05 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Lifecore Biomedical (NASDAQ:LFCR)

Current
Institutional Ownership
Percentage
83.36%
Number of
Institutional Buyers
(last 12 months)
37
Total
Institutional Inflows
(last 12 months)
$17.06M
Number of
Institutional Sellers
(last 12 months)
20
Total
Institutional Outflows
(last 12 months)
$15.34M
Get LFCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lifecore Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LFCR Institutional Buying and Selling by Quarter

Lifecore Biomedical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/16/2026 SG Americas Securities LLC17,279$64K0.0%N/A0.046%
2/18/2026Millennium Management LLC251,705$2.06M0.0%+86.2%0.672%
2/17/2026AQR Capital Management LLC16,171$132K0.0%+28.4%0.043%
2/17/2026Jump Financial LLC15,061$123K0.0%N/A0.040%
2/17/2026Price T Rowe Associates Inc. MD16,646$137K0.0%+20.4%0.044%
2/17/2026State of Wisconsin Investment Board37,825$309K0.0%+138.2%0.101%
2/17/2026Graham Capital Management L.P.13,580$111K0.0%N/A0.036%
2/16/2026Squarepoint Ops LLC110,499$904K0.0%-26.8%0.295%
2/16/2026Wittenberg Investment Management Inc.21,723$178K0.1%+26.1%0.058%
2/16/2026Barclays PLC46,696$382K0.0%+15.1%0.125%
2/13/2026Marshall Wace LLP110,621$905K0.0%-3.0%0.295%
2/13/2026Quinn Opportunity Partners LLC242,670$1.99M0.1%+31.5%0.648%
2/13/2026State Street Corp585,386$4.79M0.0%+8.5%1.562%
2/13/2026Greenhaven Road Investment Management L.P.3,682,573$30.12M5.0%-0.3%9.828%
2/13/2026 Wells Fargo & Company MN30,757$252K0.0%+69.7%0.082%
2/12/2026MetLife Investment Management LLC10,660$87K0.0%-35.4%0.028%
2/11/2026 DCF Advisers LLC442,000$3.62M1.0%-2.2%1.180%
2/11/2026 Deutsche Bank AG20,947$171K0.0%-21.5%0.056%
2/11/2026 LPL Financial LLC112,790$923K0.0%-23.9%0.301%
2/10/2026Goldman Sachs Group Inc.93,651$766K0.0%+69.2%0.250%
2/10/2026 Intech Investment Management LLC11,724$96K0.0%-12.5%0.031%
2/9/2026Geode Capital Management LLC779,642$6.38M0.0%+0.8%2.081%
1/29/2026 China Universal Asset Management Co. Ltd.6,105$50K0.0%N/A0.016%
1/1/2026JPMorgan Chase & Co.12,304$91K0.0%-12.1%0.033%
11/17/2025 PharVision Advisers LLC20,510$151K0.1%N/A0.055%
11/17/2025Quarry LP3,783$28K0.0%N/A0.010%
11/17/2025Qube Research & Technologies Ltd14,133$104K0.0%-20.0%0.038%
11/17/2025Millennium Management LLC135,205$995K0.0%+99.6%0.361%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,540$92K0.0%-17.0%0.033%
11/17/2025Citadel Advisors LLC66,752$491K0.0%+127.1%0.178%
11/17/2025Bank of America Corp DE17,284$127K0.0%-15.9%0.046%
11/17/2025Boothbay Fund Management LLC29,964$221K0.0%N/A0.080%
11/14/2025Legion Partners Asset Management LLC4,461,823$32.84M17.8%+0.7%11.909%
11/14/2025Squarepoint Ops LLC150,909$1.11M0.0%+385.9%0.403%
11/14/2025Quinn Opportunity Partners LLC184,481$1.36M0.1%-8.8%0.492%
11/13/2025 Landscape Capital Management L.L.C.37,822$278K0.0%-72.3%0.101%
11/13/2025 UBS Group AG92,828$683K0.0%-4.0%0.248%
11/13/2025 BNP Paribas Financial Markets5,791$43K0.0%+92.7%0.015%
11/12/2025 DCF Advisers LLC452,000$3.33M1.1%-2.4%1.206%
11/12/2025 Intech Investment Management LLC13,402$99K0.0%-22.4%0.036%
Microscopic Footage Shows Immune Cells Attacking Cancer (Ad)

Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.tc pixel

Watch the footage and learn about the company's next catalyst
11/7/2025Vanguard Group Inc.1,622,769$11.94M0.0%+0.8%4.331%
11/7/2025JPMorgan Chase & Co.12,304$91K0.0%-12.1%0.033%
10/20/2025 Diversified Trust Co18,146$134K0.0%-60.6%0.048%
8/19/2025State of Wyoming8,504$69K0.0%N/A0.023%
8/18/2025 Tactive Advisors LLC15,495$126K0.0%N/A0.041%
8/15/2025Grizzlyrock Capital LLC734,533$5.96M4.1%N/A1.963%
8/15/2025Bank of America Corp DE20,545$167K0.0%-24.6%0.055%
8/14/2025The Manufacturers Life Insurance Company 10,854$88K0.0%N/A0.029%
8/14/2025Qube Research & Technologies Ltd17,666$143K0.0%-68.1%0.047%
8/14/202522NW LP264,180$2.15M1.5%-84.9%0.706%
8/14/2025Pale Fire Capital SE30,686$249K0.0%N/A0.082%
8/13/2025Diametric Capital LP33,472$272K0.1%N/A0.089%
8/13/2025Marshall Wace LLP35,352$287K0.0%-47.9%0.094%
8/13/2025Greenhaven Road Investment Management L.P.3,694,832$30.00M10.3%+2.2%9.877%
8/13/2025 Invesco Ltd.379,413$3.08M0.0%N/A1.014%
8/12/2025 Steward Partners Investment Advisory LLC32,761$266K0.0%+8.4%0.088%
8/12/2025 DCF Advisers LLC462,987$3.76M1.7%-4.1%1.238%
8/12/2025 Rhumbline Advisers38,091$309K0.0%+54.0%0.102%
8/11/2025 ARS Investment Partners LLC25,000$203K0.0%+150.0%0.068%
8/11/2025Wittenberg Investment Management Inc.17,223$140K0.1%+40.9%0.047%
8/8/2025 Intech Investment Management LLC17,263$140K0.0%+62.8%0.047%
8/8/2025Geode Capital Management LLC775,493$6.30M0.0%+3.3%2.095%
8/8/2025Quinn Opportunity Partners LLC202,252$1.64M0.1%+31.8%0.546%
8/1/2025GWN Securities Inc.13,088$106K0.0%N/A0.035%
6/27/2025Goldman Sachs Group Inc.87,998$620K0.0%+16.8%0.238%
5/29/2025Rhumbline Advisers24,730$174K0.0%-55.6%0.067%
5/16/2025Goldman Sachs Group Inc.87,998$620K0.0%+16.8%0.238%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,785$104K0.0%+14.6%0.040%
5/14/2025Gamco Investors INC. ET AL84,500$595K0.0%-1.7%0.228%
5/14/2025Alpha Wave Global LP72,260$509K0.2%-38.0%0.195%
5/14/2025MetLife Investment Management LLC10,787$76K0.0%-25.7%0.029%
5/13/2025Summit Securities Group LLC3,690$26K0.0%N/A0.010%
5/13/2025Boston Partners34,175$241K0.0%N/A0.092%
5/13/2025Lepercq De Neuflize Asset Management LLC19,700$139K0.1%-13.2%0.053%
5/12/2025Nuveen LLC28,837$203K0.0%N/A0.078%
5/9/2025Charles Schwab Investment Management Inc.79,495$560K0.0%+6.8%0.215%
5/9/2025DCF Advisers LLC483,000$3.40M1.6%-10.6%1.305%
5/8/2025XTX Topco Ltd20,599$145K0.0%N/A0.056%
5/7/2025Hurley Capital LLC5,000$35K0.0%N/A0.014%
4/29/2025Bank of New York Mellon Corp83,663$589K0.0%+3.8%0.226%
4/8/2025Rhumbline Advisers24,730$174K0.0%-55.6%0.067%
4/7/2025GAMMA Investing LLC3,569$25K0.0%+1,839.7%0.010%
4/1/2025MassMutual Private Wealth & Trust FSB4,687$33K0.0%-83.3%0.013%
2/17/2025Squarepoint Ops LLC10,073$75K0.0%-63.7%0.027%
2/17/2025Legion Partners Asset Management LLC4,431,823$32.93M22.0%+49.3%11.968%
2/17/2025Deutsche Bank AG25,433$189K0.0%-91.9%0.069%
2/17/2025Bridgeway Capital Management LLC78,800$585K0.0%+2.5%0.213%
2/17/2025Bank of America Corp DE33,507$249K0.0%+25.3%0.090%
2/17/2025BNP Paribas Financial Markets14,966$111K0.0%-72.5%0.040%
2/17/2025325 Capital LLC2,162,466$16.07M6.2%+57.9%5.840%
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
2/14/2025Northern Trust Corp221,498$1.65M0.0%+14.5%0.598%
2/14/2025Boothbay Fund Management LLC87,142$647K0.0%-53.4%0.235%
2/14/2025MetLife Investment Management LLC14,513$108K0.0%N/A0.039%
2/14/2025Greenhaven Road Investment Management L.P.3,616,146$26.87M4.3%+62.2%9.765%
2/14/2025Alpha Wave Global LP116,538$866K0.4%N/A0.315%
2/13/2025Marshall Wace LLP133,191$990K0.0%-33.6%0.360%
2/13/2025Gabelli Funds LLC13,500$100K0.0%-25.0%0.036%
2/13/2025Barclays PLC33,972$253K0.0%+13.5%0.092%
2/13/2025Invesco Ltd.555,607$4.13M0.0%N/A1.500%
2/13/2025Wells Fargo & Company MN13,381$99K0.0%+29.0%0.036%


LFCR Institutional Ownership - Frequently Asked Questions

During the previous two years, 76 institutional investors and hedge funds held shares of Lifecore Biomedical. The most heavily invested institutionals were Legion Partners Asset Management LLC ($32.84M), Greenhaven Road Investment Management L.P. ($30.12M), 325 Capital LLC ($16.07M), Vanguard Group Inc. ($11.94M), Geode Capital Management LLC ($6.38M), Grizzlyrock Capital LLC ($5.96M), and State Street Corp ($4.79M).Learn more on Lifecore Biomedical's institutional investors.

83.36% of Lifecore Biomedical's stock is owned by institutional investors. Learn more on LFCR's institutional investor holdings.

Of the 64 institutional investors that purchased Lifecore Biomedical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Legion Partners Asset Management LLC ($1.51M), Greenhaven Road Investment Management L.P. ($1.47M), Invesco Ltd. ($935.02K), 325 Capital LLC ($792.68K), Grizzlyrock Capital LLC ($734.53K), DCF Advisers LLC ($257.51K), and Millennium Management LLC ($183.96K).

Institutional investors have bought a total of 2,141,571 shares in the last 24 months. This purchase volume represents approximately $17.06M in transactions.

Of the 18 institutional investors that sold Lifecore Biomedical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: 22NW LP ($1.49M), Landscape Capital Management L.L.C. ($98.59K), Qube Research & Technologies Ltd ($41.27K), DCF Advisers LLC ($41K), Squarepoint Ops LLC ($40.41K), Marshall Wace LLP ($35.92K), and LPL Financial LLC ($35.40K).

Institutional investors have sold a total of 1,909,376 shares in the last 24 months. This volume of shares sold represents approximately $15.34M in transactions.



This page (NASDAQ:LFCR) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners